Logo image of SYM

SYMBOTIC INC (SYM) Stock Fundamental Analysis

USA - NASDAQ:SYM - US87151X1019 - Common Stock

68.52 USD
-3.67 (-5.08%)
Last: 10/17/2025, 8:00:01 PM
68.94 USD
+0.42 (+0.61%)
After Hours: 10/17/2025, 8:00:01 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SYM. SYM was compared to 130 industry peers in the Machinery industry. The financial health of SYM is average, but there are quite some concerns on its profitability. SYM is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SYM had positive earnings in the past year.
In the past year SYM had a positive cash flow from operations.
In the past 5 years SYM always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: SYM reported negative operating cash flow in multiple years.
SYM Yearly Net Income VS EBIT VS OCF VS FCFSYM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.87%, SYM is doing worse than 69.23% of the companies in the same industry.
SYM has a worse Return On Equity (-7.50%) than 73.85% of its industry peers.
Industry RankSector Rank
ROA -0.87%
ROE -7.5%
ROIC N/A
ROA(3y)-1.41%
ROA(5y)-24.27%
ROE(3y)-9735.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SYM Yearly ROA, ROE, ROICSYM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

1.3 Margins

Looking at the Gross Margin, with a value of 16.86%, SYM is doing worse than 79.23% of the companies in the same industry.
In the last couple of years the Gross Margin of SYM has grown nicely.
SYM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.29%
GM growth 5YN/A
SYM Yearly Profit, Operating, Gross MarginsSYM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

6

2. Health

2.1 Basic Checks

SYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SYM has been increased compared to 1 year ago.
SYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SYM Yearly Shares OutstandingSYM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYM Yearly Total Debt VS Total AssetsSYM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 15.05 indicates that SYM is not in any danger for bankruptcy at the moment.
SYM's Altman-Z score of 15.05 is amongst the best of the industry. SYM outperforms 96.15% of its industry peers.
There is no outstanding debt for SYM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.05
ROIC/WACCN/A
WACC9.46%
SYM Yearly LT Debt VS Equity VS FCFSYM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

SYM has a Current Ratio of 1.08. This is a normal value and indicates that SYM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.08, SYM is doing worse than 85.38% of the companies in the same industry.
SYM has a Quick Ratio of 1.08. This is a bad value and indicates that SYM is not financially healthy enough and could expect problems in meeting its short term obligations.
SYM has a worse Quick ratio (0.98) than 66.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.98
SYM Yearly Current Assets VS Current LiabilitesSYM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

SYM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 186.39%, which is quite impressive.
Looking at the last year, SYM shows a very strong growth in Revenue. The Revenue has grown by 27.17%.
SYM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 77.99% yearly.
EPS 1Y (TTM)186.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%678.95%
Revenue 1Y (TTM)27.17%
Revenue growth 3Y92.19%
Revenue growth 5Y77.99%
Sales Q2Q%20.38%

3.2 Future

The Earnings Per Share is expected to grow by 121.68% on average over the next years. This is a very strong growth
Based on estimates for the next years, SYM will show a very strong growth in Revenue. The Revenue will grow by 23.18% on average per year.
EPS Next Y741.4%
EPS Next 2Y343.48%
EPS Next 3Y169.77%
EPS Next 5Y121.68%
Revenue Next Year27.07%
Revenue Next 2Y23.68%
Revenue Next 3Y25.75%
Revenue Next 5Y23.18%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SYM Yearly Revenue VS EstimatesSYM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
SYM Yearly EPS VS EstimatesSYM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 456.80, the valuation of SYM can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of SYM indicates a slightly more expensive valuation: SYM is more expensive than 72.31% of the companies listed in the same industry.
SYM is valuated expensively when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 99.45 indicates a quite expensive valuation of SYM.
Based on the Price/Forward Earnings ratio, SYM is valued a bit more expensive than the industry average as 70.77% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of SYM to the average of the S&P500 Index (22.94), we can say SYM is valued expensively.
Industry RankSector Rank
PE 456.8
Fwd PE 99.45
SYM Price Earnings VS Forward Price EarningsSYM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

SYM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. SYM is more expensive than 67.69% of the companies in the same industry.
Industry RankSector Rank
P/FCF 233.39
EV/EBITDA N/A
SYM Per share dataSYM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SYM's earnings are expected to grow with 169.76% in the coming years.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y343.48%
EPS Next 3Y169.77%

0

5. Dividend

5.1 Amount

SYM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SYMBOTIC INC

NASDAQ:SYM (10/17/2025, 8:00:01 PM)

After market: 68.94 +0.42 (+0.61%)

68.52

-3.67 (-5.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-17 2025-11-17/bmo
Inst Owners80.43%
Inst Owner Change-0.11%
Ins Owners0.44%
Ins Owner Change-0.41%
Market Cap40.46B
Analysts69.57
Price Target50.56 (-26.21%)
Short Float %14.58%
Short Ratio6.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)26.19%
Min EPS beat(2)-121.96%
Max EPS beat(2)174.34%
EPS beat(4)2
Avg EPS beat(4)-15.32%
Min EPS beat(4)-121.96%
Max EPS beat(4)174.34%
EPS beat(8)4
Avg EPS beat(8)-18.85%
EPS beat(12)4
Avg EPS beat(12)-49.64%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.32%
Min Revenue beat(2)2.7%
Max Revenue beat(2)9.94%
Revenue beat(4)3
Avg Revenue beat(4)8.06%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)21.43%
Revenue beat(8)6
Avg Revenue beat(8)8.02%
Revenue beat(12)10
Avg Revenue beat(12)13.62%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.8%
PT rev (3m)30.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)38.65%
EPS NY rev (1m)0%
EPS NY rev (3m)18.57%
Revenue NQ rev (1m)-0.32%
Revenue NQ rev (3m)-4.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 456.8
Fwd PE 99.45
P/S 18.98
P/FCF 233.39
P/OCF 170.81
P/B 191.98
P/tB 601.21
EV/EBITDA N/A
EPS(TTM)0.15
EY0.22%
EPS(NY)0.69
Fwd EY1.01%
FCF(TTM)0.29
FCFY0.43%
OCF(TTM)0.4
OCFY0.59%
SpS3.61
BVpS0.36
TBVpS0.11
PEG (NY)0.62
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.87%
ROE -7.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.86%
FCFM 8.13%
ROA(3y)-1.41%
ROA(5y)-24.27%
ROE(3y)-9735.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.29%
GM growth 5YN/A
F-Score6
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 156.6%
Cap/Sales 2.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 0.98
Altman-Z 15.05
F-Score6
WACC9.46%
ROIC/WACCN/A
Cap/Depr(3y)206.19%
Cap/Depr(5y)195.83%
Cap/Sales(3y)2.24%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)186.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%678.95%
EPS Next Y741.4%
EPS Next 2Y343.48%
EPS Next 3Y169.77%
EPS Next 5Y121.68%
Revenue 1Y (TTM)27.17%
Revenue growth 3Y92.19%
Revenue growth 5Y77.99%
Sales Q2Q%20.38%
Revenue Next Year27.07%
Revenue Next 2Y23.68%
Revenue Next 3Y25.75%
Revenue Next 5Y23.18%
EBIT growth 1Y34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year268.89%
EBIT Next 3Y94.35%
EBIT Next 5Y70.45%
FCF growth 1Y61.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.72%
OCF growth 3YN/A
OCF growth 5YN/A